Selvedge Venture
Overview
A venture capital firm founded in 2021 and based in London, United Kingdom. The firm seeks to invest in pre-seed, seed, and Series A deep technology companies operating in the life sciences and healthcare sectors, with a mission to alleviate the healthcare burden caused by age-related medical conditions like Metabolic Syndrome, Cancer, and Neurodegenerative Diseases. Its core expertise lies at the intersection of Biotechnology and Digital Technologies.
Portfolio Companies
4
Website
selvedgeventure.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Oxford Medical Products | Mar 2022 | VC Round | Lead |
| BIOS Health | Jun 2023 | Series A | Lead |
| Sanome | Sep 2021 | Seed | Co-investor |
| Exogene | Apr 2022 | Seed | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Selvedge Venture based?
Selvedge Venture is headquartered in London, England, United Kingdom.
When was Selvedge Venture founded?
Founding year information for Selvedge Venture is not publicly available.
How many portfolio companies does Selvedge Venture have?
Selvedge Venture has 4 portfolio companies in Caplight's dataset.
What are some companies in Selvedge Venture's portfolio?
Portfolio companies visible on Caplight include Oxford Medical Products, BIOS Health, Sanome, Exogene.
What was Selvedge Venture's most recent investment shown here?
Selvedge Venture's most recent investment in this portfolio sample was in BIOS Health in 2023.
What sectors does Selvedge Venture focus on?
Selvedge Venture focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure.
What company stages does Selvedge Venture focus on?
Selvedge Venture typically invests at the Early stage.
What is Selvedge Venture's AUM?
Selvedge Venture's assets under management are estimated at over $14.0M.